Powerful psychotropic drugs are often the next step, even though their combined effects in young children haven’t been ...

Centanafadine is a first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor (NDSRI). Clinical studies have shown that centanafadine significantly reduces core symptoms of ADHD in ...

The general public underestimates the potential dangers associated with the use of ADHD medications. Here are a few commonly overlooked facts. Campus Safety recently took a comprehensive look the ...

We both treat ADHD patients with medication, and we are used to drug company representatives trying to show us the “latest and greatest” pharmaceutical innovation for ADHD. Unfortunately as noted in ...

For nearly five years, people with attention deficit/hyperactivity disorder have had the option of getting their stimulant medications prescribed and renewed by doctors they see only over a computer ...

About 1 in 14 children and adolescents in the U.S. are diagnosed with ADHD, a chronic condition that includes attention difficulty, hyperactivity and impulsiveness. In the most common form of ADHD ...

ADHD can also lead to ill-health and is associated with a higher risk of premature mortality or shortened lifespan. This ...

A new study finds that children with congenital heart disease and ADHD can take stimulant medications without fear of significant cardiovascular side effects. In a study to be presented at a national ...

Pfizer and manufacturer Tris Pharma have agreed to hand over $41.5 million to lay to rest a 2023 lawsuit accusing the ...

People taking medications for ADHD, or attention-deficit hyperactivity disorder, may face disruptions in accessing treatment after the arrests of two executives of a telehealth company that ...

Attention-deficit/hyperactivity disorder (ADHD) is often treated with stimulant medications. These can be effective and may be necessary for severe cases. However ...